nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—PTGS1—kidney cancer	0.233	0.486	CbGaD
Salicylic acid—PTGS2—kidney cancer	0.133	0.278	CbGaD
Salicylic acid—ABCB1—kidney cancer	0.113	0.236	CbGaD
Salicylic acid—SLCO2B1—Erlotinib—kidney cancer	0.0905	0.284	CbGbCtD
Salicylic acid—ABCB1—Temsirolimus—kidney cancer	0.0358	0.112	CbGbCtD
Salicylic acid—ALB—Erlotinib—kidney cancer	0.0256	0.0804	CbGbCtD
Salicylic acid—CYP2C9—Capecitabine—kidney cancer	0.0202	0.0633	CbGbCtD
Salicylic acid—ABCB1—Pazopanib—kidney cancer	0.0188	0.0589	CbGbCtD
Salicylic acid—ABCB1—Dactinomycin—kidney cancer	0.0172	0.0539	CbGbCtD
Salicylic acid—ABCB1—Gemcitabine—kidney cancer	0.0136	0.0426	CbGbCtD
Salicylic acid—ABCB1—Erlotinib—kidney cancer	0.0134	0.042	CbGbCtD
Salicylic acid—CYP2C9—Paclitaxel—kidney cancer	0.0126	0.0397	CbGbCtD
Salicylic acid—ABCB1—Paclitaxel—kidney cancer	0.0123	0.0385	CbGbCtD
Salicylic acid—CYP2C9—Sorafenib—kidney cancer	0.0112	0.0352	CbGbCtD
Salicylic acid—ABCB1—Sorafenib—kidney cancer	0.0109	0.0342	CbGbCtD
Salicylic acid—ABCB1—Vinblastine—kidney cancer	0.0108	0.0338	CbGbCtD
Salicylic acid—ABCB1—Vincristine—kidney cancer	0.0106	0.0332	CbGbCtD
Salicylic acid—ABCB1—Sunitinib—kidney cancer	0.00884	0.0277	CbGbCtD
Salicylic acid—ABCB1—Doxorubicin—kidney cancer	0.00662	0.0207	CbGbCtD
Salicylic acid—SLC22A8—nephron—kidney cancer	0.00453	0.111	CbGeAlD
Salicylic acid—SLC22A8—urine—kidney cancer	0.00364	0.0888	CbGeAlD
Salicylic acid—PTGS2—nephron—kidney cancer	0.00257	0.0628	CbGeAlD
Salicylic acid—CYP2C9—urine—kidney cancer	0.00236	0.0577	CbGeAlD
Salicylic acid—SLC22A11—nephron tubule—kidney cancer	0.00173	0.0424	CbGeAlD
Salicylic acid—SLC22A6—nephron tubule—kidney cancer	0.00163	0.0399	CbGeAlD
Salicylic acid—SLC22A11—renal system—kidney cancer	0.00158	0.0385	CbGeAlD
Salicylic acid—SLC22A7—renal system—kidney cancer	0.00154	0.0376	CbGeAlD
Salicylic acid—SLC22A11—kidney—kidney cancer	0.00152	0.0372	CbGeAlD
Salicylic acid—SLC22A7—kidney—kidney cancer	0.00149	0.0363	CbGeAlD
Salicylic acid—SLC22A11—cortex of kidney—kidney cancer	0.00148	0.0363	CbGeAlD
Salicylic acid—SLC22A7—cortex of kidney—kidney cancer	0.00145	0.0354	CbGeAlD
Salicylic acid—SLC22A6—cortex of kidney—kidney cancer	0.0014	0.0342	CbGeAlD
Salicylic acid—SLC16A1—renal system—kidney cancer	0.00118	0.0287	CbGeAlD
Salicylic acid—SLC16A1—kidney—kidney cancer	0.00114	0.0278	CbGeAlD
Salicylic acid—SLC16A1—gonad—kidney cancer	0.00106	0.0258	CbGeAlD
Salicylic acid—SLC16A1—cardiac atrium—kidney cancer	0.00105	0.0257	CbGeAlD
Salicylic acid—SLCO2B1—renal system—kidney cancer	0.00101	0.0247	CbGeAlD
Salicylic acid—SLCO2B1—kidney—kidney cancer	0.000979	0.0239	CbGeAlD
Salicylic acid—SLC22A8—nephron tubule—kidney cancer	0.000979	0.0239	CbGeAlD
Salicylic acid—SLC22A8—renal system—kidney cancer	0.00089	0.0217	CbGeAlD
Salicylic acid—SLC22A8—kidney—kidney cancer	0.00086	0.021	CbGeAlD
Salicylic acid—SLC22A8—cortex of kidney—kidney cancer	0.000838	0.0205	CbGeAlD
Salicylic acid—Acetylsalicylic acid—TP53—kidney cancer	0.000684	0.125	CrCbGaD
Salicylic acid—Salicylate-sodium—PTGS1—kidney cancer	0.000538	0.0984	CrCbGaD
Salicylic acid—Abdominal discomfort—Sunitinib—kidney cancer	0.000531	0.00552	CcSEcCtD
Salicylic acid—Hepatitis—Everolimus—kidney cancer	0.000531	0.00552	CcSEcCtD
Salicylic acid—Lightheadedness—Paclitaxel—kidney cancer	0.000531	0.00552	CcSEcCtD
Salicylic acid—Hallucination—Everolimus—kidney cancer	0.000528	0.00549	CcSEcCtD
Salicylic acid—PTGS1—renal system—kidney cancer	0.000528	0.0129	CbGeAlD
Salicylic acid—Hepatitis—Erlotinib—kidney cancer	0.000512	0.00533	CcSEcCtD
Salicylic acid—Hearing impaired—Capecitabine—kidney cancer	0.000512	0.00532	CcSEcCtD
Salicylic acid—PTGS1—kidney—kidney cancer	0.00051	0.0125	CbGeAlD
Salicylic acid—Oedema—Temsirolimus—kidney cancer	0.000507	0.00527	CcSEcCtD
Salicylic acid—PTGS2—renal system—kidney cancer	0.000505	0.0123	CbGeAlD
Salicylic acid—PTGS2—kidney—kidney cancer	0.000488	0.0119	CbGeAlD
Salicylic acid—Erythema multiforme—Erlotinib—kidney cancer	0.000485	0.00504	CcSEcCtD
Salicylic acid—Epistaxis—Sorafenib—kidney cancer	0.000484	0.00504	CcSEcCtD
Salicylic acid—Anorexia—Temsirolimus—kidney cancer	0.000484	0.00503	CcSEcCtD
Salicylic acid—Deafness—Paclitaxel—kidney cancer	0.000482	0.00501	CcSEcCtD
Salicylic acid—Oedema—Pazopanib—kidney cancer	0.000478	0.00497	CcSEcCtD
Salicylic acid—PTGS1—cardiac atrium—kidney cancer	0.000473	0.0115	CbGeAlD
Salicylic acid—Epistaxis—Sunitinib—kidney cancer	0.000466	0.00485	CcSEcCtD
Salicylic acid—Skin exfoliation—Capecitabine—kidney cancer	0.000465	0.00483	CcSEcCtD
Salicylic acid—Erythema—Everolimus—kidney cancer	0.000462	0.00481	CcSEcCtD
Salicylic acid—Anorexia—Pazopanib—kidney cancer	0.000456	0.00474	CcSEcCtD
Salicylic acid—Dysgeusia—Everolimus—kidney cancer	0.000453	0.00471	CcSEcCtD
Salicylic acid—Burning sensation—Doxorubicin—kidney cancer	0.000452	0.0047	CcSEcCtD
Salicylic acid—Somnolence—Temsirolimus—kidney cancer	0.000451	0.00469	CcSEcCtD
Salicylic acid—Erythema—Erlotinib—kidney cancer	0.000446	0.00464	CcSEcCtD
Salicylic acid—Oesophagitis—Capecitabine—kidney cancer	0.000445	0.00463	CcSEcCtD
Salicylic acid—Hepatitis—Sunitinib—kidney cancer	0.000444	0.00461	CcSEcCtD
Salicylic acid—Decreased appetite—Temsirolimus—kidney cancer	0.000441	0.00458	CcSEcCtD
Salicylic acid—Ecchymosis—Capecitabine—kidney cancer	0.00044	0.00458	CcSEcCtD
Salicylic acid—Lethargy—Paclitaxel—kidney cancer	0.00044	0.00457	CcSEcCtD
Salicylic acid—Erythema multiforme—Sorafenib—kidney cancer	0.000436	0.00453	CcSEcCtD
Salicylic acid—Constipation—Temsirolimus—kidney cancer	0.000434	0.00451	CcSEcCtD
Salicylic acid—Pain—Temsirolimus—kidney cancer	0.000434	0.00451	CcSEcCtD
Salicylic acid—Tinnitus—Sorafenib—kidney cancer	0.00043	0.00447	CcSEcCtD
Salicylic acid—Somnolence—Pazopanib—kidney cancer	0.000425	0.00442	CcSEcCtD
Salicylic acid—Dyspepsia—Pazopanib—kidney cancer	0.000421	0.00437	CcSEcCtD
Salicylic acid—Hepatitis—Dactinomycin—kidney cancer	0.00042	0.00437	CcSEcCtD
Salicylic acid—Erythema multiforme—Sunitinib—kidney cancer	0.000419	0.00436	CcSEcCtD
Salicylic acid—Decreased appetite—Pazopanib—kidney cancer	0.000415	0.00432	CcSEcCtD
Salicylic acid—Pain—Pazopanib—kidney cancer	0.000409	0.00425	CcSEcCtD
Salicylic acid—Erythema—Sorafenib—kidney cancer	0.000401	0.00417	CcSEcCtD
Salicylic acid—Erythema multiforme—Dactinomycin—kidney cancer	0.000397	0.00413	CcSEcCtD
Salicylic acid—Deafness—Capecitabine—kidney cancer	0.000395	0.00411	CcSEcCtD
Salicylic acid—Abdominal pain upper—Paclitaxel—kidney cancer	0.000393	0.00409	CcSEcCtD
Salicylic acid—Dysgeusia—Sorafenib—kidney cancer	0.000393	0.00409	CcSEcCtD
Salicylic acid—Stinging—Doxorubicin—kidney cancer	0.000387	0.00403	CcSEcCtD
Salicylic acid—Erythema—Sunitinib—kidney cancer	0.000386	0.00401	CcSEcCtD
Salicylic acid—Dysgeusia—Sunitinib—kidney cancer	0.000378	0.00393	CcSEcCtD
Salicylic acid—Oedema—Everolimus—kidney cancer	0.000377	0.00392	CcSEcCtD
Salicylic acid—Hallucination—Vincristine—kidney cancer	0.000373	0.00388	CcSEcCtD
Salicylic acid—Magnesium salicylate—PTGS1—kidney cancer	0.000369	0.0674	CrCbGaD
Salicylic acid—Erythema—Dactinomycin—kidney cancer	0.000366	0.0038	CcSEcCtD
Salicylic acid—Oedema—Erlotinib—kidney cancer	0.000364	0.00378	CcSEcCtD
Salicylic acid—Anorexia—Vinblastine—kidney cancer	0.000361	0.00375	CcSEcCtD
Salicylic acid—Lethargy—Capecitabine—kidney cancer	0.000361	0.00375	CcSEcCtD
Salicylic acid—Anorexia—Everolimus—kidney cancer	0.00036	0.00374	CcSEcCtD
Salicylic acid—Pruritus—Temsirolimus—kidney cancer	0.000359	0.00373	CcSEcCtD
Salicylic acid—Diarrhoea—Temsirolimus—kidney cancer	0.000347	0.00361	CcSEcCtD
Salicylic acid—Anorexia—Erlotinib—kidney cancer	0.000347	0.00361	CcSEcCtD
Salicylic acid—Aminosalicylic Acid—PTGS1—kidney cancer	0.000347	0.0634	CrCbGaD
Salicylic acid—Diflunisal—PTGS1—kidney cancer	0.000347	0.0634	CrCbGaD
Salicylic acid—ABCB1—nephron tubule—kidney cancer	0.000343	0.00838	CbGeAlD
Salicylic acid—Weight increased—Paclitaxel—kidney cancer	0.000339	0.00352	CcSEcCtD
Salicylic acid—Pruritus—Pazopanib—kidney cancer	0.000338	0.00351	CcSEcCtD
Salicylic acid—Erythema multiforme—Gemcitabine—kidney cancer	0.000337	0.0035	CcSEcCtD
Salicylic acid—Somnolence—Everolimus—kidney cancer	0.000335	0.00349	CcSEcCtD
Salicylic acid—Dizziness—Temsirolimus—kidney cancer	0.000335	0.00349	CcSEcCtD
Salicylic acid—Dyspepsia—Everolimus—kidney cancer	0.000332	0.00345	CcSEcCtD
Salicylic acid—Decreased appetite—Vinblastine—kidney cancer	0.000329	0.00342	CcSEcCtD
Salicylic acid—Decreased appetite—Everolimus—kidney cancer	0.000328	0.00341	CcSEcCtD
Salicylic acid—Diarrhoea—Pazopanib—kidney cancer	0.000327	0.0034	CcSEcCtD
Salicylic acid—Pain—Vinblastine—kidney cancer	0.000324	0.00337	CcSEcCtD
Salicylic acid—Constipation—Vinblastine—kidney cancer	0.000324	0.00337	CcSEcCtD
Salicylic acid—Abdominal pain upper—Capecitabine—kidney cancer	0.000323	0.00336	CcSEcCtD
Salicylic acid—Constipation—Everolimus—kidney cancer	0.000323	0.00335	CcSEcCtD
Salicylic acid—Pain—Everolimus—kidney cancer	0.000323	0.00335	CcSEcCtD
Salicylic acid—Vomiting—Temsirolimus—kidney cancer	0.000323	0.00335	CcSEcCtD
Salicylic acid—Dyspepsia—Erlotinib—kidney cancer	0.00032	0.00333	CcSEcCtD
Salicylic acid—Rash—Temsirolimus—kidney cancer	0.00032	0.00332	CcSEcCtD
Salicylic acid—Dermatitis—Temsirolimus—kidney cancer	0.00032	0.00332	CcSEcCtD
Salicylic acid—Headache—Temsirolimus—kidney cancer	0.000318	0.0033	CcSEcCtD
Salicylic acid—Decreased appetite—Erlotinib—kidney cancer	0.000316	0.00329	CcSEcCtD
Salicylic acid—Dizziness—Pazopanib—kidney cancer	0.000316	0.00329	CcSEcCtD
Salicylic acid—Oedema—Sunitinib—kidney cancer	0.000315	0.00328	CcSEcCtD
Salicylic acid—Salsalate—PTGS1—kidney cancer	0.000313	0.0574	CrCbGaD
Salicylic acid—Epistaxis—Paclitaxel—kidney cancer	0.000313	0.00326	CcSEcCtD
Salicylic acid—Anorexia—Sorafenib—kidney cancer	0.000312	0.00325	CcSEcCtD
Salicylic acid—Feeling abnormal—Vinblastine—kidney cancer	0.000312	0.00324	CcSEcCtD
Salicylic acid—ABCB1—renal system—kidney cancer	0.000312	0.00762	CbGeAlD
Salicylic acid—Constipation—Erlotinib—kidney cancer	0.000311	0.00324	CcSEcCtD
Salicylic acid—Pain—Erlotinib—kidney cancer	0.000311	0.00324	CcSEcCtD
Salicylic acid—Feeling abnormal—Everolimus—kidney cancer	0.000311	0.00323	CcSEcCtD
Salicylic acid—Erythema—Gemcitabine—kidney cancer	0.00031	0.00322	CcSEcCtD
Salicylic acid—Meclofenamic acid—PTGS1—kidney cancer	0.000309	0.0565	CrCbGaD
Salicylic acid—Salicylate-sodium—PTGS2—kidney cancer	0.000307	0.0563	CrCbGaD
Salicylic acid—Asthma—Capecitabine—kidney cancer	0.000306	0.00318	CcSEcCtD
Salicylic acid—Vomiting—Pazopanib—kidney cancer	0.000304	0.00316	CcSEcCtD
Salicylic acid—ABCB1—kidney—kidney cancer	0.000302	0.00737	CbGeAlD
Salicylic acid—Rash—Pazopanib—kidney cancer	0.000301	0.00313	CcSEcCtD
Salicylic acid—Nausea—Temsirolimus—kidney cancer	0.000301	0.00313	CcSEcCtD
Salicylic acid—Dermatitis—Pazopanib—kidney cancer	0.000301	0.00313	CcSEcCtD
Salicylic acid—Anorexia—Sunitinib—kidney cancer	0.0003	0.00312	CcSEcCtD
Salicylic acid—Skin exfoliation—Doxorubicin—kidney cancer	0.0003	0.00312	CcSEcCtD
Salicylic acid—Headache—Pazopanib—kidney cancer	0.000299	0.00311	CcSEcCtD
Salicylic acid—Oedema—Dactinomycin—kidney cancer	0.000298	0.0031	CcSEcCtD
Salicylic acid—ABCB1—cortex of kidney—kidney cancer	0.000294	0.00718	CbGeAlD
Salicylic acid—Abdominal discomfort—Capecitabine—kidney cancer	0.000293	0.00304	CcSEcCtD
Salicylic acid—Dyspepsia—Sorafenib—kidney cancer	0.000288	0.003	CcSEcCtD
Salicylic acid—Oesophagitis—Doxorubicin—kidney cancer	0.000287	0.00298	CcSEcCtD
Salicylic acid—Decreased appetite—Sorafenib—kidney cancer	0.000285	0.00296	CcSEcCtD
Salicylic acid—Anorexia—Dactinomycin—kidney cancer	0.000284	0.00296	CcSEcCtD
Salicylic acid—Nausea—Pazopanib—kidney cancer	0.000284	0.00295	CcSEcCtD
Salicylic acid—Ecchymosis—Doxorubicin—kidney cancer	0.000284	0.00295	CcSEcCtD
Salicylic acid—Erythema multiforme—Paclitaxel—kidney cancer	0.000282	0.00293	CcSEcCtD
Salicylic acid—Pain—Sorafenib—kidney cancer	0.00028	0.00291	CcSEcCtD
Salicylic acid—Constipation—Sorafenib—kidney cancer	0.00028	0.00291	CcSEcCtD
Salicylic acid—ABCB1—gonad—kidney cancer	0.00028	0.00683	CbGeAlD
Salicylic acid—Weight increased—Capecitabine—kidney cancer	0.000278	0.00289	CcSEcCtD
Salicylic acid—Tinnitus—Paclitaxel—kidney cancer	0.000278	0.00289	CcSEcCtD
Salicylic acid—Dyspepsia—Sunitinib—kidney cancer	0.000277	0.00288	CcSEcCtD
Salicylic acid—Decreased appetite—Sunitinib—kidney cancer	0.000274	0.00285	CcSEcCtD
Salicylic acid—Mesalazine—PTGS1—kidney cancer	0.000272	0.0498	CrCbGaD
Salicylic acid—Constipation—Sunitinib—kidney cancer	0.00027	0.0028	CcSEcCtD
Salicylic acid—Pain—Sunitinib—kidney cancer	0.00027	0.0028	CcSEcCtD
Salicylic acid—Pruritus—Everolimus—kidney cancer	0.000267	0.00278	CcSEcCtD
Salicylic acid—Oedema—Vincristine—kidney cancer	0.000267	0.00277	CcSEcCtD
Salicylic acid—Urticaria—Sorafenib—kidney cancer	0.00026	0.0027	CcSEcCtD
Salicylic acid—Erythema—Paclitaxel—kidney cancer	0.000259	0.0027	CcSEcCtD
Salicylic acid—Decreased appetite—Dactinomycin—kidney cancer	0.000259	0.0027	CcSEcCtD
Salicylic acid—Diarrhoea—Vinblastine—kidney cancer	0.000259	0.00269	CcSEcCtD
Salicylic acid—Diarrhoea—Everolimus—kidney cancer	0.000258	0.00268	CcSEcCtD
Salicylic acid—Pruritus—Erlotinib—kidney cancer	0.000258	0.00268	CcSEcCtD
Salicylic acid—Epistaxis—Capecitabine—kidney cancer	0.000257	0.00267	CcSEcCtD
Salicylic acid—Pain—Dactinomycin—kidney cancer	0.000255	0.00265	CcSEcCtD
Salicylic acid—Anorexia—Vincristine—kidney cancer	0.000254	0.00264	CcSEcCtD
Salicylic acid—Dysgeusia—Paclitaxel—kidney cancer	0.000254	0.00264	CcSEcCtD
Salicylic acid—Oedema—Gemcitabine—kidney cancer	0.000253	0.00263	CcSEcCtD
Salicylic acid—Dizziness—Vinblastine—kidney cancer	0.00025	0.0026	CcSEcCtD
Salicylic acid—Dizziness—Everolimus—kidney cancer	0.00025	0.00259	CcSEcCtD
Salicylic acid—Diarrhoea—Erlotinib—kidney cancer	0.000249	0.00259	CcSEcCtD
Salicylic acid—Feeling abnormal—Dactinomycin—kidney cancer	0.000246	0.00256	CcSEcCtD
Salicylic acid—Hepatitis—Capecitabine—kidney cancer	0.000245	0.00254	CcSEcCtD
Salicylic acid—Anorexia—Gemcitabine—kidney cancer	0.000241	0.00251	CcSEcCtD
Salicylic acid—Vomiting—Vinblastine—kidney cancer	0.000241	0.0025	CcSEcCtD
Salicylic acid—Dizziness—Erlotinib—kidney cancer	0.000241	0.0025	CcSEcCtD
Salicylic acid—Mefenamic acid—PTGS1—kidney cancer	0.00024	0.044	CrCbGaD
Salicylic acid—Vomiting—Everolimus—kidney cancer	0.00024	0.00249	CcSEcCtD
Salicylic acid—Rash—Everolimus—kidney cancer	0.000238	0.00247	CcSEcCtD
Salicylic acid—Dermatitis—Everolimus—kidney cancer	0.000238	0.00247	CcSEcCtD
Salicylic acid—Headache—Vinblastine—kidney cancer	0.000237	0.00247	CcSEcCtD
Salicylic acid—Headache—Everolimus—kidney cancer	0.000236	0.00246	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—PTGS1—kidney cancer	0.000234	0.0428	CrCbGaD
Salicylic acid—Lethargy—Doxorubicin—kidney cancer	0.000233	0.00242	CcSEcCtD
Salicylic acid—Decreased appetite—Vincristine—kidney cancer	0.000232	0.00241	CcSEcCtD
Salicylic acid—Pruritus—Sorafenib—kidney cancer	0.000232	0.00241	CcSEcCtD
Salicylic acid—Vomiting—Erlotinib—kidney cancer	0.000231	0.00241	CcSEcCtD
Salicylic acid—Erythema multiforme—Capecitabine—kidney cancer	0.000231	0.0024	CcSEcCtD
Salicylic acid—Rash—Erlotinib—kidney cancer	0.00023	0.00239	CcSEcCtD
Salicylic acid—Dermatitis—Erlotinib—kidney cancer	0.000229	0.00238	CcSEcCtD
Salicylic acid—Headache—Erlotinib—kidney cancer	0.000228	0.00237	CcSEcCtD
Salicylic acid—Tinnitus—Capecitabine—kidney cancer	0.000228	0.00237	CcSEcCtD
Salicylic acid—Constipation—Vincristine—kidney cancer	0.000228	0.00237	CcSEcCtD
Salicylic acid—Pain—Vincristine—kidney cancer	0.000228	0.00237	CcSEcCtD
Salicylic acid—Nausea—Vinblastine—kidney cancer	0.000225	0.00234	CcSEcCtD
Salicylic acid—Somnolence—Gemcitabine—kidney cancer	0.000225	0.00234	CcSEcCtD
Salicylic acid—Nausea—Everolimus—kidney cancer	0.000224	0.00233	CcSEcCtD
Salicylic acid—Diarrhoea—Sorafenib—kidney cancer	0.000224	0.00233	CcSEcCtD
Salicylic acid—Pruritus—Sunitinib—kidney cancer	0.000223	0.00232	CcSEcCtD
Salicylic acid—Decreased appetite—Gemcitabine—kidney cancer	0.00022	0.00229	CcSEcCtD
Salicylic acid—Dizziness—Sorafenib—kidney cancer	0.000217	0.00225	CcSEcCtD
Salicylic acid—Pain—Gemcitabine—kidney cancer	0.000216	0.00225	CcSEcCtD
Salicylic acid—Constipation—Gemcitabine—kidney cancer	0.000216	0.00225	CcSEcCtD
Salicylic acid—Nausea—Erlotinib—kidney cancer	0.000216	0.00225	CcSEcCtD
Salicylic acid—Diarrhoea—Sunitinib—kidney cancer	0.000216	0.00224	CcSEcCtD
Salicylic acid—Confusional state—Paclitaxel—kidney cancer	0.000213	0.00222	CcSEcCtD
Salicylic acid—Erythema—Capecitabine—kidney cancer	0.000213	0.00221	CcSEcCtD
Salicylic acid—Oedema—Paclitaxel—kidney cancer	0.000212	0.0022	CcSEcCtD
Salicylic acid—Magnesium salicylate—PTGS2—kidney cancer	0.000211	0.0386	CrCbGaD
Salicylic acid—Dysgeusia—Capecitabine—kidney cancer	0.000208	0.00217	CcSEcCtD
Salicylic acid—Dizziness—Sunitinib—kidney cancer	0.000208	0.00217	CcSEcCtD
Salicylic acid—Feeling abnormal—Gemcitabine—kidney cancer	0.000208	0.00217	CcSEcCtD
Salicylic acid—Vomiting—Sorafenib—kidney cancer	0.000208	0.00216	CcSEcCtD
Salicylic acid—Abdominal pain upper—Doxorubicin—kidney cancer	0.000208	0.00216	CcSEcCtD
Salicylic acid—Rash—Sorafenib—kidney cancer	0.000207	0.00215	CcSEcCtD
Salicylic acid—Dermatitis—Sorafenib—kidney cancer	0.000206	0.00214	CcSEcCtD
Salicylic acid—Headache—Sorafenib—kidney cancer	0.000205	0.00213	CcSEcCtD
Salicylic acid—Diarrhoea—Dactinomycin—kidney cancer	0.000204	0.00212	CcSEcCtD
Salicylic acid—Anorexia—Paclitaxel—kidney cancer	0.000202	0.0021	CcSEcCtD
Salicylic acid—Vomiting—Sunitinib—kidney cancer	0.0002	0.00208	CcSEcCtD
Salicylic acid—Rash—Sunitinib—kidney cancer	0.000199	0.00207	CcSEcCtD
Salicylic acid—Dermatitis—Sunitinib—kidney cancer	0.000199	0.00206	CcSEcCtD
Salicylic acid—Diflunisal—PTGS2—kidney cancer	0.000198	0.0363	CrCbGaD
Salicylic acid—Aminosalicylic Acid—PTGS2—kidney cancer	0.000198	0.0363	CrCbGaD
Salicylic acid—Headache—Sunitinib—kidney cancer	0.000197	0.00205	CcSEcCtD
Salicylic acid—Asthma—Doxorubicin—kidney cancer	0.000197	0.00205	CcSEcCtD
Salicylic acid—Nausea—Sorafenib—kidney cancer	0.000195	0.00202	CcSEcCtD
Salicylic acid—Vomiting—Dactinomycin—kidney cancer	0.00019	0.00197	CcSEcCtD
Salicylic acid—Somnolence—Paclitaxel—kidney cancer	0.000188	0.00196	CcSEcCtD
Salicylic acid—Rash—Dactinomycin—kidney cancer	0.000188	0.00196	CcSEcCtD
Salicylic acid—Nausea—Sunitinib—kidney cancer	0.000187	0.00195	CcSEcCtD
Salicylic acid—Dyspepsia—Paclitaxel—kidney cancer	0.000186	0.00194	CcSEcCtD
Salicylic acid—Decreased appetite—Paclitaxel—kidney cancer	0.000184	0.00191	CcSEcCtD
Salicylic acid—Diarrhoea—Vincristine—kidney cancer	0.000182	0.0019	CcSEcCtD
Salicylic acid—Pain—Paclitaxel—kidney cancer	0.000181	0.00188	CcSEcCtD
Salicylic acid—Constipation—Paclitaxel—kidney cancer	0.000181	0.00188	CcSEcCtD
Salicylic acid—Weight increased—Doxorubicin—kidney cancer	0.000179	0.00186	CcSEcCtD
Salicylic acid—Salsalate—PTGS2—kidney cancer	0.000179	0.0328	CrCbGaD
Salicylic acid—Pruritus—Gemcitabine—kidney cancer	0.000179	0.00186	CcSEcCtD
Salicylic acid—Nausea—Dactinomycin—kidney cancer	0.000177	0.00184	CcSEcCtD
Salicylic acid—Meclofenamic acid—PTGS2—kidney cancer	0.000177	0.0323	CrCbGaD
Salicylic acid—Dizziness—Vincristine—kidney cancer	0.000176	0.00183	CcSEcCtD
Salicylic acid—Drowsiness—Doxorubicin—kidney cancer	0.000176	0.00183	CcSEcCtD
Salicylic acid—Confusional state—Capecitabine—kidney cancer	0.000175	0.00182	CcSEcCtD
Salicylic acid—Feeling abnormal—Paclitaxel—kidney cancer	0.000174	0.00181	CcSEcCtD
Salicylic acid—Oedema—Capecitabine—kidney cancer	0.000174	0.00181	CcSEcCtD
Salicylic acid—Diarrhoea—Gemcitabine—kidney cancer	0.000173	0.0018	CcSEcCtD
Salicylic acid—Vomiting—Vincristine—kidney cancer	0.000169	0.00176	CcSEcCtD
Salicylic acid—Urticaria—Paclitaxel—kidney cancer	0.000168	0.00175	CcSEcCtD
Salicylic acid—Rash—Vincristine—kidney cancer	0.000168	0.00175	CcSEcCtD
Salicylic acid—Dermatitis—Vincristine—kidney cancer	0.000168	0.00175	CcSEcCtD
Salicylic acid—Headache—Vincristine—kidney cancer	0.000167	0.00174	CcSEcCtD
Salicylic acid—Epistaxis—Doxorubicin—kidney cancer	0.000166	0.00172	CcSEcCtD
Salicylic acid—Anorexia—Capecitabine—kidney cancer	0.000166	0.00172	CcSEcCtD
Salicylic acid—Vomiting—Gemcitabine—kidney cancer	0.000161	0.00167	CcSEcCtD
Salicylic acid—Rash—Gemcitabine—kidney cancer	0.000159	0.00166	CcSEcCtD
Salicylic acid—Dermatitis—Gemcitabine—kidney cancer	0.000159	0.00166	CcSEcCtD
Salicylic acid—Headache—Gemcitabine—kidney cancer	0.000158	0.00165	CcSEcCtD
Salicylic acid—Nausea—Vincristine—kidney cancer	0.000158	0.00165	CcSEcCtD
Salicylic acid—Hepatitis—Doxorubicin—kidney cancer	0.000158	0.00164	CcSEcCtD
Salicylic acid—Mesalazine—PTGS2—kidney cancer	0.000155	0.0284	CrCbGaD
Salicylic acid—Dyspepsia—Capecitabine—kidney cancer	0.000153	0.00159	CcSEcCtD
Salicylic acid—Decreased appetite—Capecitabine—kidney cancer	0.000151	0.00157	CcSEcCtD
Salicylic acid—Nausea—Gemcitabine—kidney cancer	0.00015	0.00156	CcSEcCtD
Salicylic acid—Pruritus—Paclitaxel—kidney cancer	0.00015	0.00156	CcSEcCtD
Salicylic acid—Erythema multiforme—Doxorubicin—kidney cancer	0.000149	0.00155	CcSEcCtD
Salicylic acid—Pain—Capecitabine—kidney cancer	0.000149	0.00154	CcSEcCtD
Salicylic acid—Constipation—Capecitabine—kidney cancer	0.000149	0.00154	CcSEcCtD
Salicylic acid—Tinnitus—Doxorubicin—kidney cancer	0.000147	0.00153	CcSEcCtD
Salicylic acid—Diarrhoea—Paclitaxel—kidney cancer	0.000145	0.00151	CcSEcCtD
Salicylic acid—Feeling abnormal—Capecitabine—kidney cancer	0.000143	0.00149	CcSEcCtD
Salicylic acid—Dizziness—Paclitaxel—kidney cancer	0.00014	0.00146	CcSEcCtD
Salicylic acid—Urticaria—Capecitabine—kidney cancer	0.000138	0.00143	CcSEcCtD
Salicylic acid—Mefenamic acid—PTGS2—kidney cancer	0.000137	0.0251	CrCbGaD
Salicylic acid—Erythema—Doxorubicin—kidney cancer	0.000137	0.00143	CcSEcCtD
Salicylic acid—Vomiting—Paclitaxel—kidney cancer	0.000135	0.0014	CcSEcCtD
Salicylic acid—Dysgeusia—Doxorubicin—kidney cancer	0.000134	0.0014	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—PTGS2—kidney cancer	0.000134	0.0245	CrCbGaD
Salicylic acid—Rash—Paclitaxel—kidney cancer	0.000133	0.00139	CcSEcCtD
Salicylic acid—Dermatitis—Paclitaxel—kidney cancer	0.000133	0.00139	CcSEcCtD
Salicylic acid—Headache—Paclitaxel—kidney cancer	0.000133	0.00138	CcSEcCtD
Salicylic acid—Nausea—Paclitaxel—kidney cancer	0.000126	0.00131	CcSEcCtD
Salicylic acid—Pruritus—Capecitabine—kidney cancer	0.000123	0.00128	CcSEcCtD
Salicylic acid—Diarrhoea—Capecitabine—kidney cancer	0.000119	0.00124	CcSEcCtD
Salicylic acid—Dizziness—Capecitabine—kidney cancer	0.000115	0.00119	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—ABCB1—kidney cancer	0.000114	0.0208	CrCbGaD
Salicylic acid—Confusional state—Doxorubicin—kidney cancer	0.000113	0.00117	CcSEcCtD
Salicylic acid—Oedema—Doxorubicin—kidney cancer	0.000112	0.00116	CcSEcCtD
Salicylic acid—Vomiting—Capecitabine—kidney cancer	0.00011	0.00115	CcSEcCtD
Salicylic acid—Rash—Capecitabine—kidney cancer	0.00011	0.00114	CcSEcCtD
Salicylic acid—Dermatitis—Capecitabine—kidney cancer	0.000109	0.00114	CcSEcCtD
Salicylic acid—Headache—Capecitabine—kidney cancer	0.000109	0.00113	CcSEcCtD
Salicylic acid—Anorexia—Doxorubicin—kidney cancer	0.000107	0.00111	CcSEcCtD
Salicylic acid—Nausea—Capecitabine—kidney cancer	0.000103	0.00107	CcSEcCtD
Salicylic acid—Somnolence—Doxorubicin—kidney cancer	9.96e-05	0.00104	CcSEcCtD
Salicylic acid—Dyspepsia—Doxorubicin—kidney cancer	9.86e-05	0.00102	CcSEcCtD
Salicylic acid—Decreased appetite—Doxorubicin—kidney cancer	9.74e-05	0.00101	CcSEcCtD
Salicylic acid—Constipation—Doxorubicin—kidney cancer	9.58e-05	0.000996	CcSEcCtD
Salicylic acid—Pain—Doxorubicin—kidney cancer	9.58e-05	0.000996	CcSEcCtD
Salicylic acid—Feeling abnormal—Doxorubicin—kidney cancer	9.23e-05	0.000959	CcSEcCtD
Salicylic acid—Urticaria—Doxorubicin—kidney cancer	8.9e-05	0.000925	CcSEcCtD
Salicylic acid—Pruritus—Doxorubicin—kidney cancer	7.92e-05	0.000824	CcSEcCtD
Salicylic acid—Diarrhoea—Doxorubicin—kidney cancer	7.66e-05	0.000797	CcSEcCtD
Salicylic acid—Dizziness—Doxorubicin—kidney cancer	7.41e-05	0.00077	CcSEcCtD
Salicylic acid—Vomiting—Doxorubicin—kidney cancer	7.12e-05	0.00074	CcSEcCtD
Salicylic acid—Rash—Doxorubicin—kidney cancer	7.06e-05	0.000734	CcSEcCtD
Salicylic acid—Dermatitis—Doxorubicin—kidney cancer	7.06e-05	0.000733	CcSEcCtD
Salicylic acid—Headache—Doxorubicin—kidney cancer	7.02e-05	0.000729	CcSEcCtD
Salicylic acid—Nausea—Doxorubicin—kidney cancer	6.65e-05	0.000692	CcSEcCtD
Salicylic acid—AKR1C1—Metabolism—PTGS2—kidney cancer	1.72e-05	0.000295	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GSTM1—kidney cancer	1.7e-05	0.000291	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPAT—kidney cancer	1.7e-05	0.000291	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GLIPR1—kidney cancer	1.7e-05	0.000291	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GPC3—kidney cancer	1.69e-05	0.00029	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.69e-05	0.00029	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—MAPK1—kidney cancer	1.68e-05	0.000287	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IFNA2—kidney cancer	1.66e-05	0.000285	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.65e-05	0.000284	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.65e-05	0.000283	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CRABP1—kidney cancer	1.65e-05	0.000283	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CA2—kidney cancer	1.65e-05	0.000282	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	1.64e-05	0.000282	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CYP1A1—kidney cancer	1.61e-05	0.000276	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RPL14—kidney cancer	1.61e-05	0.000276	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ALAD—kidney cancer	1.61e-05	0.000275	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.6e-05	0.000274	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	1.6e-05	0.000274	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.6e-05	0.000274	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPAT—kidney cancer	1.59e-05	0.000272	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.59e-05	0.000272	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—KRAS—kidney cancer	1.58e-05	0.000271	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—FH—kidney cancer	1.58e-05	0.000271	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—APRT—kidney cancer	1.58e-05	0.000271	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.57e-05	0.00027	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ST3GAL2—kidney cancer	1.57e-05	0.000269	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.57e-05	0.000268	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.56e-05	0.000267	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.56e-05	0.000267	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.55e-05	0.000266	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CA9—kidney cancer	1.54e-05	0.000265	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ITPR2—kidney cancer	1.54e-05	0.000263	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ALDH1A1—kidney cancer	1.53e-05	0.000263	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MAPK3—kidney cancer	1.53e-05	0.000262	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.52e-05	0.000261	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.52e-05	0.000261	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.51e-05	0.000259	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PTEN—kidney cancer	1.5e-05	0.000257	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IGF2—kidney cancer	1.5e-05	0.000257	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MYC—kidney cancer	1.49e-05	0.000255	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RAF1—kidney cancer	1.49e-05	0.000255	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GPC3—kidney cancer	1.48e-05	0.000254	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RELA—kidney cancer	1.48e-05	0.000253	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—FH—kidney cancer	1.47e-05	0.000253	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—APRT—kidney cancer	1.47e-05	0.000253	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ERBB2—kidney cancer	1.47e-05	0.000252	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PGK1—kidney cancer	1.47e-05	0.000252	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SLC5A3—kidney cancer	1.47e-05	0.000252	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ITPR2—kidney cancer	1.46e-05	0.00025	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MAPK1—kidney cancer	1.45e-05	0.000249	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—PIK3CA—kidney cancer	1.45e-05	0.000249	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MTOR—kidney cancer	1.45e-05	0.000249	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.45e-05	0.000248	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CA2—kidney cancer	1.44e-05	0.000247	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.44e-05	0.000247	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.44e-05	0.000247	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—LDHB—kidney cancer	1.44e-05	0.000247	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.44e-05	0.000247	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	1.43e-05	0.000246	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.42e-05	0.000243	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALAD—kidney cancer	1.41e-05	0.000241	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TP53—kidney cancer	1.41e-05	0.000241	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ACHE—kidney cancer	1.4e-05	0.00024	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTT1—kidney cancer	1.4e-05	0.00024	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.4e-05	0.00024	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GPC3—kidney cancer	1.39e-05	0.000238	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.38e-05	0.000236	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—KRAS—kidney cancer	1.37e-05	0.000236	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.37e-05	0.000235	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.37e-05	0.000235	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.37e-05	0.000235	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.36e-05	0.000234	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CDKN1B—kidney cancer	1.36e-05	0.000233	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CA2—kidney cancer	1.35e-05	0.000231	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.34e-05	0.00023	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL2—kidney cancer	1.33e-05	0.000228	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.33e-05	0.000228	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—SCARB1—kidney cancer	1.33e-05	0.000227	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.32e-05	0.000227	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALAD—kidney cancer	1.31e-05	0.000225	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CRABP1—kidney cancer	1.31e-05	0.000225	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCND1—kidney cancer	1.3e-05	0.000223	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—JUN—kidney cancer	1.3e-05	0.000222	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PSMD7—kidney cancer	1.29e-05	0.000221	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PGK1—kidney cancer	1.29e-05	0.000221	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC5A3—kidney cancer	1.29e-05	0.000221	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CTNNB1—kidney cancer	1.29e-05	0.00022	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.28e-05	0.00022	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.28e-05	0.000219	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PIK3CA—kidney cancer	1.26e-05	0.000216	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—LDHB—kidney cancer	1.26e-05	0.000216	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.26e-05	0.000216	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.25e-05	0.000215	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PTEN—kidney cancer	1.25e-05	0.000215	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CA9—kidney cancer	1.25e-05	0.000214	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—BCHE—kidney cancer	1.22e-05	0.000209	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PSMD7—kidney cancer	1.22e-05	0.000209	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.22e-05	0.000209	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ITPR2—kidney cancer	1.22e-05	0.000209	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.22e-05	0.000209	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—SLC5A5—kidney cancer	1.21e-05	0.000207	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PGK1—kidney cancer	1.2e-05	0.000206	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.2e-05	0.000206	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—POMC—kidney cancer	1.2e-05	0.000206	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.2e-05	0.000206	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—LDHB—kidney cancer	1.18e-05	0.000202	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—SLC2A1—kidney cancer	1.16e-05	0.0002	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.15e-05	0.000198	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.14e-05	0.000195	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—VEGFA—kidney cancer	1.13e-05	0.000194	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.13e-05	0.000194	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.12e-05	0.000193	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTT1—kidney cancer	1.11e-05	0.000191	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ACHE—kidney cancer	1.11e-05	0.000191	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SLC2A1—kidney cancer	1.1e-05	0.000189	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.1e-05	0.000189	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.1e-05	0.000188	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—JUNB—kidney cancer	1.1e-05	0.000188	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CA9—kidney cancer	1.09e-05	0.000188	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.08e-05	0.000185	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MAPK3—kidney cancer	1.07e-05	0.000184	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CRABP1—kidney cancer	1.06e-05	0.000182	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PIK3CA—kidney cancer	1.06e-05	0.000181	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SCARB1—kidney cancer	1.05e-05	0.000181	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTGS1—kidney cancer	1.04e-05	0.000179	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—kidney cancer	1.04e-05	0.000178	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PSMD7—kidney cancer	1.02e-05	0.000175	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CA9—kidney cancer	1.02e-05	0.000175	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.02e-05	0.000175	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MAPK1—kidney cancer	1.02e-05	0.000175	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.99e-06	0.000171	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ITPR2—kidney cancer	9.87e-06	0.000169	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.86e-06	0.000169	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTP1—kidney cancer	9.72e-06	0.000167	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—BCHE—kidney cancer	9.69e-06	0.000166	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—KRAS—kidney cancer	9.62e-06	0.000165	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGS2—kidney cancer	9.58e-06	0.000164	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SLC5A5—kidney cancer	9.58e-06	0.000164	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	9.52e-06	0.000163	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.37e-06	0.000161	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CRABP1—kidney cancer	9.3e-06	0.000159	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SLC2A1—kidney cancer	9.25e-06	0.000158	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ABCB1—kidney cancer	9.2e-06	0.000158	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.1e-06	0.000156	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.07e-06	0.000155	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTT1—kidney cancer	9e-06	0.000154	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ACHE—kidney cancer	9e-06	0.000154	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTM1—kidney cancer	8.93e-06	0.000153	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN2B—kidney cancer	8.92e-06	0.000153	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CA—kidney cancer	8.84e-06	0.000152	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CRABP1—kidney cancer	8.69e-06	0.000149	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ITPR2—kidney cancer	8.65e-06	0.000148	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—kidney cancer	8.55e-06	0.000147	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SCARB1—kidney cancer	8.52e-06	0.000146	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP1A1—kidney cancer	8.46e-06	0.000145	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS1—kidney cancer	8.44e-06	0.000145	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTEN—kidney cancer	8.36e-06	0.000143	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PSMD7—kidney cancer	8.27e-06	0.000142	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RAF1—kidney cancer	8.24e-06	0.000141	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ITPR2—kidney cancer	8.08e-06	0.000138	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ACHE—kidney cancer	7.89e-06	0.000135	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTT1—kidney cancer	7.89e-06	0.000135	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—BCHE—kidney cancer	7.84e-06	0.000134	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.83e-06	0.000134	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SLC5A5—kidney cancer	7.75e-06	0.000133	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTP1—kidney cancer	7.71e-06	0.000132	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SLC2A1—kidney cancer	7.48e-06	0.000128	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SCARB1—kidney cancer	7.47e-06	0.000128	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.45e-06	0.000128	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS1—kidney cancer	7.39e-06	0.000127	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2—kidney cancer	7.39e-06	0.000127	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTT1—kidney cancer	7.37e-06	0.000126	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ACHE—kidney cancer	7.37e-06	0.000126	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ABCB1—kidney cancer	7.3e-06	0.000125	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.26e-06	0.000124	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PSMD7—kidney cancer	7.25e-06	0.000124	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	7.14e-06	0.000122	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HIF1A—kidney cancer	7.13e-06	0.000122	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TSC2—kidney cancer	7.12e-06	0.000122	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTM1—kidney cancer	7.09e-06	0.000121	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SCARB1—kidney cancer	6.98e-06	0.00012	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.95e-06	0.000119	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS1—kidney cancer	6.91e-06	0.000118	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BCHE—kidney cancer	6.87e-06	0.000118	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC5A5—kidney cancer	6.79e-06	0.000116	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PSMD7—kidney cancer	6.77e-06	0.000116	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP1A1—kidney cancer	6.72e-06	0.000115	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC2A1—kidney cancer	6.56e-06	0.000112	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BCHE—kidney cancer	6.42e-06	0.00011	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.34e-06	0.000109	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.33e-06	0.000108	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—POMC—kidney cancer	6.31e-06	0.000108	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KIT—kidney cancer	6.28e-06	0.000108	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APC—kidney cancer	6.28e-06	0.000108	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VEGFA—kidney cancer	6.28e-06	0.000108	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.25e-06	0.000107	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTP1—kidney cancer	6.24e-06	0.000107	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.12e-06	0.000105	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.94e-06	0.000102	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK3—kidney cancer	5.94e-06	0.000102	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—BRAF—kidney cancer	5.91e-06	0.000101	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ABCB1—kidney cancer	5.91e-06	0.000101	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CA—kidney cancer	5.9e-06	0.000101	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTM1—kidney cancer	5.73e-06	9.83e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK1—kidney cancer	5.65e-06	9.69e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.52e-06	9.46e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTP1—kidney cancer	5.47e-06	9.37e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP1A1—kidney cancer	5.44e-06	9.32e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—KRAS—kidney cancer	5.34e-06	9.15e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.18e-06	8.88e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTP1—kidney cancer	5.11e-06	8.75e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGS2—kidney cancer	5.03e-06	8.63e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTM1—kidney cancer	5.02e-06	8.61e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—POMC—kidney cancer	5.01e-06	8.59e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RAF1—kidney cancer	4.93e-06	8.45e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CA—kidney cancer	4.91e-06	8.41e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB2—kidney cancer	4.88e-06	8.36e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ABCB1—kidney cancer	4.84e-06	8.29e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MTOR—kidney cancer	4.82e-06	8.25e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD4—kidney cancer	4.81e-06	8.24e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP1A1—kidney cancer	4.76e-06	8.16e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—kidney cancer	4.75e-06	8.13e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTM1—kidney cancer	4.69e-06	8.04e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN1B—kidney cancer	4.52e-06	7.74e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.47e-06	7.65e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.45e-06	7.63e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTEN—kidney cancer	4.39e-06	7.52e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CTNNB1—kidney cancer	4.27e-06	7.32e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PTEN—kidney cancer	4.16e-06	7.13e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—POMC—kidney cancer	4.05e-06	6.95e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.66e-06	6.27e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAPK3—kidney cancer	3.56e-06	6.09e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—POMC—kidney cancer	3.55e-06	6.09e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTEN—kidney cancer	3.48e-06	5.97e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—kidney cancer	3.46e-06	5.93e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAPK1—kidney cancer	3.38e-06	5.8e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—POMC—kidney cancer	3.32e-06	5.69e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS2—kidney cancer	3.23e-06	5.54e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KRAS—kidney cancer	3.2e-06	5.48e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CA—kidney cancer	3.1e-06	5.31e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CA—kidney cancer	2.94e-06	5.03e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS2—kidney cancer	2.83e-06	4.85e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTEN—kidney cancer	2.82e-06	4.83e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS2—kidney cancer	2.65e-06	4.54e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTEN—kidney cancer	2.47e-06	4.23e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CA—kidney cancer	2.46e-06	4.21e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTEN—kidney cancer	2.31e-06	3.96e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CA—kidney cancer	1.99e-06	3.41e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CA—kidney cancer	1.74e-06	2.99e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.63e-06	2.79e-05	CbGpPWpGaD
